Related Experiment Video

Updated: Jun 20, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

New therapies for non-muscle-invasive bladder cancer

Edmund Chiong1, Kesavan Esuvaranathan

  • 1Department of Urology, National University Hospital, Singapore 119074, Singapore.

World Journal of Urology
|September 19, 2009
PubMed

Insights

New treatments for non-muscle-invasive bladder cancer (NMIBC) offer improved outcomes. Advances include novel immunotherapies, chemotherapies, and enhanced drug delivery methods for better bladder cancer management.

Area of Science:

  • Oncology
  • Urology

Background:

  • Non-muscle-invasive bladder cancer (NMIBC) presents challenges due to high recurrence rates and potential progression to muscle-invasive disease.
  • Current treatment modalities for NMIBC have suboptimal outcomes.
  • There is a need for more effective therapeutic strategies for NMIBC management.

Purpose of the Study:

  • To review recent pre-clinical and clinical developments in NMIBC treatment.
  • To categorize recent advances in NMIBC management.
  • To highlight emerging therapeutic options for bladder cancer.

Main Methods:

  • Review of recent pre-clinical and clinical literature on NMIBC treatments.
  • Categorization of therapeutic developments into immunotherapy, chemotherapeutic agents, enhanced delivery, and gene therapy.
  • Analysis of advancements in bladder cancer management.

Main Results:

  • Substantive advances in therapeutic options for NMIBC have emerged.
  • New chemotherapeutic drugs and improved delivery methods are being developed.
  • Novel approaches like gene therapy and immunotherapy show promise.

Conclusions:

  • Recent developments offer improved therapeutic options for NMIBC.
  • Combination therapy and multimodal approaches are gaining traction.
  • Further research into novel treatments like immunotherapy and gene therapy is warranted for better bladder cancer control.

More Related Videos

An Orthotopic Bladder Cancer Model for Gene Delivery Studies07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...